Infantile Ganglioneuroblastoma Causing Growth Failure and Hypertensive Cardiomyopathy From Excessive Catecholamine...

Area of Science:

• Pediatric Oncology
• Cardiology
• Endocrinology

Background:

• Neuroblastomas are common pediatric extracranial tumors.
• Cardiomyopathy and heart failure are rare complications of neuroblastomas, unlike pheochromocytomas.
• Excessive catecholamine production can lead to severe hypertension and cardiac dysfunction.

Purpose of the Study:

• To report a rare case of hypertensive cardiomyopathy in a child caused by a ganglioneuroblastoma.
• To highlight the diagnostic and therapeutic challenges associated with neuroblastoma-induced cardiac complications.
• To emphasize the importance of a multidisciplinary approach in managing such complex cases.

Main Methods:

• Case report of a 3-year-old girl with growth failure and hypertensive cardiomyopathy.
• Diagnostic workup included assessment of catecholamine levels and histopathologic analysis.
• Treatment involved alpha-blockers, medications, and surgical tumor resection.

Main Results:

• The patient presented with hypertensive cardiomyopathy due to excessive epinephrine and norepinephrine production from a ganglioneuroblastoma.
• Medical management with alpha-blockers improved circulation, allowing for partial tumor resection.
• Subtotal resection was ultimately required to reduce catecholamine levels, as initial chemotherapy (James' therapy) was ineffective for tumor shrinkage.

Conclusions:

• Ganglioneuroblastomas can cause severe hypertensive cardiomyopathy in children.
• Multidisciplinary treatment is crucial for managing patients with neuroblastoma-related excess catecholamines and cardiac complications.
• Early recognition and intervention are vital for improving outcomes in these rare cases.